Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials

Abstract Introduction Limited data exist on skin cancer risk in patients with psoriasis using biologics. Here, we report treatment-emergent adverse events (TEAEs) of skin cancer in patients treated with ixekizumab from psoriasis clinical trials. Methods Integrated safety databases from 17 clinical t...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Saxon D. Smith, Alexandros Stratigos, Matthias Augustin, Jose Manuel Carrascosa, Susanne Grond, Elisabeth Riedl, Wen Xu, Himanshu Patel, Mark Lebwohl
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Adis, Springer Healthcare 2023-06-01
Serie:	Dermatology and Therapy
Soggetti:	Ixekizumab Long-term Malignancy Melanoma Non-melanoma skin cancer Psoriasis
Accesso online:	https://doi.org/10.1007/s13555-023-00966-4
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!